FDA Inspection 1235600 — Seattle Children's Hospital

Seattle Children's Hospital — FEI 3003918087

The FDA completed an inspection of Seattle Children's Hospital on Apr 3, 2024 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Apr 3, 2024
Fiscal Year
2024
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Seattle, WA (United States)